{"id":320,"date":"2014-06-25T22:43:03","date_gmt":"2014-06-25T20:43:03","guid":{"rendered":"http:\/\/beta.oegpb.at\/?page_id=320"},"modified":"2021-05-13T16:58:25","modified_gmt":"2021-05-13T14:58:25","slug":"forschung-2012","status":"publish","type":"page","link":"https:\/\/oegpb.at\/?page_id=320","title":{"rendered":"Forschung 2012"},"content":{"rendered":"

[et_pb_section fb_built=“1″ _builder_version=“4.9.4″ _module_preset=“a101c382-f6f4-4378-9eee-5c6c65b689e1″ locked=“off“][et_pb_row _builder_version=“4.9.3″ _module_preset=“default“ custom_padding=“||10px||false|false“][et_pb_column type=“4_4″ _builder_version=“4.9.3″ _module_preset=“default“][et_pb_post_title _builder_version=“4.9.3″ _module_preset=“7fd05a31-4b65-4680-8d87-3be606eca9dc“][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“section“ _builder_version=“3.22″][et_pb_row admin_label=“row“ _builder_version=“4.9.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“ hover_enabled=“0″ box_shadow_style=“preset1″ custom_padding=“40px|40px|40px|40px|true|true“ custom_padding_last_edited=“on|phone“ sticky_enabled=“0″ custom_padding_phone=“|20px||20px|true|true“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text admin_label=“Text“ _builder_version=“3.27.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“]\t\t\t\t<\/p>\n

Ausgew\u00e4hlte Publikationen f\u00fcr das Jahr 2012<\/h2>\n

Aktuelle Forschungsarbeiten der Klinischen Abteilung f\u00fcr Biologische Psychiatrie, Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, Wien
\nAbteilungsvorstand:<\/strong>
\nO. Univ. Prof. Dr.h.c.mult. Dr.med. Siegfried Kasper:
\nsci-biolpsy@meduniwien.ac.at<\/a><\/p>\n

<\/a>Publikationen 2012<\/h2>\n

H\u00f6flich A, Baldinger P, Savli M, Lanzenberger R, Kasper S.<\/p>\n

Imaging treatment effects in depression
\nRev Neurosci. 2012;23(3):227-52<\/a><\/p>\n

Akimova E, Kasper S (2012)
\nAuf einen Blick: Burnout Syndrom und Depression: Eine oder zwei Seiten einer Medaille?<\/strong>
\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (4): 190-193<\/p>\n

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, M\u00f6ller HJ for the World Psychiatric Association (WPA) section of pharmacopsychiatry (2012)
\nExecutive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders<\/strong>
\nEuropean Archives of Psychiatry and Clinical Neuroscience 262 (1): 13-22<\/p>\n

Baldinger P, Hahn A, Friedl M, Kranz GS, Ungersb\u00f6ck J, H\u00f6flich A, Mitterhauser M, Rujescu D, Wadsak W, Lanzenberger R, Kasper S (2012)
\nEinfluss der HTR1A-Polymorphismus rs878567 auf das Serotonin-1A-Bindingspotenzial in vivo<\/strong>
\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (1): 36-38<\/p>\n

Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, M\u00f6ller HJ on behalf of the WFSBP Task Force on Mental Disorders in Primary Care and the WFSBP Task Force on Anxiety Disorders, OCD and PTSD (2012)
\nGuidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders in primary care<\/strong>
\nInternational Journal of Psychiatry in Clinical Practice 16 (2): 77-84<\/p>\n

Bauer M, Praschak-Rieder N, Kasper S, Willeit M (2012)
\nIs dopamine neurotransmission altered in prodromal schizophrenia? A review of evidence<\/strong>
\nCurrent Pharmaceutical Design 18 (12): 1568-1579<\/p>\n

Boubela RN, Huf W, Kalcher K, Sladky R, Filzmoser P, Pezawas L, Kasper S, Windischberger C, Moser E (2012)
\nA highly parallelized framework for computationally intensive MR data analysis<\/strong>
\nMagnetic Resonance Materials in Physics, Biology and Medicine 25 (4): 313-320<\/p>\n

Fagiolini A, Comandini A, Dell\u2019Osso MC, Kasper S (2012)
\nRediscovering trazodone for the treatment of major depressive disorder<\/strong>
\nCNS Drugs 26 (12): 1033-1049<\/p>\n

Fink M, Meshkat D, Kasper S, Winkler D (2012)
\nPsychische und Verhaltensst\u00f6rungen bei Demenz<\/strong>
\nCliniCum neuropsy 1: 22-25<\/p>\n

Fischer R, Winkler D, Pjrek E, Kasper S (2012)
\nOn the application of light therapy in German speaking countries<\/strong>
\nEuropean Archives of Psychiatry and Clinical Neurosciences 262 (6): 501-505<\/p>\n

Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, M\u00f6ller HJ, Vieta E (2012)
\nEfficacy of pharmacotherapy in bipolar disorder: a report by the WPA section of pharmacopsychiatry<\/strong>
\nEuropean Archives of Psychiatry and Clinical Neuroscience 262 (Suppl. 1): 1-48<\/p>\n

Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, M\u00f6ller HJ, Kasper S and the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2012)
\nThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania<\/strong>
\nThe World Journal of Biological Psychiatry 10: 85-116 Japanese translation from the English language edition. Tokyo: Seiwa Shoten Publishers<\/p>\n

Hahn A, Nics L, Baldinger P, Ungersb\u00f6ck J, Dolliner P, Frey R, Birkfellner W, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2012)
\nCombining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C] WAY-100635 independent of arterial sampling<\/strong>
\nNeuroImage 62 (3): 199-206<\/p>\n

Hahn A, Wadsak W, Windischberger C, Baldinger P, H\u00f6flich A, Losak J, Nics L, Philippe C, Kranz GS, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R (2012)
\nDifferential modulation of the default mode network via serotonin-1A receptors<\/strong>
\nPNAS 109 (7): 2619-2624<\/p>\n

H\u00f6flich A, Baldinger P, Lanzenberger S, Kasper S, Winkler D (2012)
\nSteckbrief seltener Krankheiten: Das Charles Bonnet Syndrom<\/strong>
\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (4): 187-189<\/p>\n

H\u00f6flich A, Baldinger P, Savli M, Lanzenberger R, Kasper S (2012)
\nImaging treatment effects in depression<\/strong>
\nReviews in the Neurosciences 23 (3): 227-252<\/p>\n

H\u00f6flich A, Kraus C, Frey R, Lanzenberger R, Kasper S (2012) Morphologische Ver\u00e4nderungen im ZNS. CliniCum neuropsy 1: 28-30 Kasper S (2012)
\nCinical data in early intervention<\/strong>
\nInternational Psychogeriatrics 24 (Suppl. 1): S41- 45<\/p>\n

Kasper S (2012)
\nPhytotherapie bei Stress und sogenanntem Burnout<\/strong>
\nPhytotherapie Austria 4: 4-5<\/p>\n

Kasper S (2012)
\nPsychiatrie, raus aus der Tabuzone! Trends & Perspektiven in der Psychiatrie<\/strong>
\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (1): 3<\/p>\n

Kasper S (2012)
\nThe challenge of treating severe depression<\/strong>
\nDepression Tribune 14: 1<\/p>\n

Kasper S (2012)
\nVorwort. In: Gregor S: D-Day 24 Stunden der Entscheidung \u2013 mein Kampf gegen die Depression<\/strong>
\nM\u00fcnchen: Scorpio Verlag, pp. 6-8<\/p>\n

Kasper S, Ebert B, Larsen K, Tonnoir B (2012)
\nCombining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder<\/strong>
\nInternational Journal of Neuropsychopharmacology 15 (6): 715-725<\/p>\n

Kasper S, Glehr R, Hasiba B, Heckenthaler W, Kapfhammer HP, Psota G, Rados C, Schultes H (2012)
\nExperten Statement: Diagnose und Therapie der Generalisierten Angstst\u00f6rung (GAD) in der allgemeinmedizinischen und psychiatrischen Praxis. Schnittstellenmanagement und Stellenwert von Pregabalin. (Update Europe)<\/strong>
\nInternationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung 18 (ISSN 1726-0027)<\/p>\n

Kasper S, Hofmann P, Erfurth A, Frey R, H\u00f6gl B, Jenny T, Klier C, Leuteritz I, Popovic R, Pramsohler B, Rados C, Rainer M, Rie\u00dfland-Seifert A, Saletu B, Saletu-Zyhlarz G, Stelzig M, Walter E, Wuschitz A (2012)
\nSchlafst\u00f6rungen bei psychiatrischen Erkrankungen<\/strong>
\nKonsensus-Statement – State of the art 2012<\/strong>
\nClinicum neuropsy Sonderausgabe November 2012)<\/p>\n

Kasper S, Lehofer M, Doering S, Geretsegger C, Frey R, Haring C, Hausmann A, Hofmann P, Jelem H, Kalousek M, Kapfhammer HP, Klier C, Oberlerchner H, Rados C, Rothenh\u00e4usler HB, Sachs GM, Praschak-Rieder N, Psota G, Rainer M, Windhager E, Winkler D, Wrobel M (2012)
\nDepression \u2013 Medikament\u00f6se Therapie. Konsensus-Statement – State of the art 2012<\/strong>
\nClinicum neuropsy Sonderausgabe November 2012<\/p>\n

Kasper S, Marksteiner J, Jilma B, Kutzelnigg A, Sachs G, Varadi E, Fruhw\u00fcrth G, Geretsegger C, Kastner A, Kaufmann D, Kopeinig M, Miksch G, Pfersmann V, Praschak-Rieder N, Stetter R, Toth A, Winklbaur-Hausknost B, Wrobel M (2012)
\nInnovative Depottherapie bei Schizophrenie<\/strong>
\nCliniCum neuropsy Sonderausgabe M\u00e4rz 2012<\/p>\n

Kasper S, Rados C, Rittmannsberger H, Lenzinger E, Konstantinidis A, Hummer M, Geretsegger C (2012)
\nAntidepressive Therapie mit Agomelatin in der Praxis \u2013 Ergebnisse einer Beobachtung an Patienten unter Alltagsbedingungen<\/strong>
\nSonderdruck September 2012 Servier Austria<\/p>\n

Kasper S, Schosser S, Lanzenberger R (2012)
\nTrends und Perspektiven in der Psychiatrie: Bildgebung und Genetik in der Psychiatrie \u2013 quo vadis?<\/strong>
\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (4): 168-169<\/p>\n

Kindler J, Frey R, Kasper S (2012) Do antidepressants increase the risk of suicide? In: Shrivastava A, Kimbrell M, Lester D (ed.)
\nSuicide from a global perspective: vulnerable populations and controversies<\/strong>
\nHauppauge: Nova Science Publishers, pp. 101-110<\/p>\n

Konstantinidis A, Kasper S (2012) Stottern induziert durch Psychopharmaka. CliniCum neuropsy 5: 28-29 Konstantinidis A, Papageorgiou K, Grohmann R, Horvath A, Engel R, Kasper S (2012)
\nIncrease of antipsychotic medication in depressive inpatients from 2000 to 2007: Results from the AMSP International Pharmacovigilance Program<\/strong>
\nInternational Journal of Neuropsychopharmacology 15 (4): 449-457<\/p>\n

Konstantinidis A, Stamenkovic M, Kasper S (2012) Krampfanfall unter Kombinationsbehandlung. CliniCum neuropsy 1: 46-47 Kostantinidis A, Kasper S (2012)
\nDepression \u2013 neue therapeutische Optionen<\/strong>
\n\u00c4rzte Woche 6: 22<\/p>\n

Kraft U, Hecher A, Kasper S (2012)
\nDysthymie<\/strong>
\nhttp:\/\/www.netdoktor.at\/krankheiten\/fakta\/dysthymie.shtml<\/a><\/p>\n

Kraus C, Hahn A, Savli M, Kranz G, Baldinger P, H\u00f6flich A, Spindelegger C, Ungersboeck J, Haeusler D, Mitterhauser M, Windischberger C, Wadsak W, Kasper S, Lanzenberger R (2012) Serotonin 1A receptor binding is positively is associated with gray matter volume – a multimodal neuroimaing study cmbining PET and structural MRI<\/strong>
\nNeuroimage 63 (3): 1091-1098<\/p>\n

Lanzenberger R, Kranz G, H\u00e4usler D, Akimova E, Savli M, Hahn A, Wadsak W, Spindelegger C, Philippe C, Fink M, Mitterhauser M, Kasper S (2012) <\/strong>
\nPrediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas<\/strong>
\nNeuroImage 63 (2): 874-881<\/p>\n

Letmaier M, Painold A, Holl AK, Vergin H, Engel R, Konstantinidis A, Kasper S, Grohmann R (2012)
\nHyponatremia during psychopharmacological treatment \u2013 a result of a drug surveillance program<\/strong>
\nInternational Journal of Neuropsychopharmacology 15 (6): 739-748<\/p>\n

Mendlewicz J, Crisafulli C, Calati R, Kocabas NA, Massat I, Linotte S, Kasper S, Fink M, Sidoti A, Scantamburlo G, Ansseau M, Antonijevic I, Forray C, Snyder L, Bollen J, Montgomery S, Zohar J, Serretti A (2012)
\nInfluence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression<\/strong>
\nNeuroscience Letters 516 (1): 85-88<\/p>\n

M\u00f6ller HJ, Bitter I, Bobes J, Fountoulakis K, H\u00f6schl C, Kasper S (2012)
\nPosition statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression<\/strong>
\nEuropean Psychiatry 27 (2): 114-12<\/p>\n

Naderi-Heiden A, Gleiss A, Baecker C, Bieber D, Nassan-Agha H, Kasper S, Frey R (2012)
\nMortality and employment after in-patient opiate detoxification<\/strong>
\nEuropean Psychiatry 27 (4): 294-300<\/p>\n

Pjrek E, Frey R, Naderi-Heiden A, Strnad A, Kowarik A, Kasper S, Winkler D (2012)
\nActigraphic measurements in opioid detoxification with methadone or buprenorphine<\/strong>
\nJournal of Clinical Psychopharmacology 32 (1): 75-82<\/p>\n

Savli M, Bauer A, Mitterhauser M, Ding YS, Hahn A, Kroll T, Neumeister A, H\u00e4usler D, Ungersb\u00f6ck J, Henry S, Attaripour Isfahani A, Rattay F, Wadsak W, Kasper S, Lanzenberger R (2012)
\nNormative database of the serotonergic system in healthy subjects using multi-tracer PET<\/strong>
\nNeuroImage 63 (1): 447-459<\/p>\n

Schl\u00e4pfer T, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt D, Kasper S (2012)
\nThe hidden third: improving outcome in treatment resistant depression<\/strong>
\nJournal of Psychopharmacology 26 (5): 587-602<\/p>\n

Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Papageorgiou K, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S (2012)
\nThe impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder \u2013 A European Multicenter Study<\/strong>
\nEuropean Neuropsychopharmacology 22 (4): 259-266<\/p>\n

Schosser A, Serretti A, Souery D, Mendlewicz J, Montgomery S, Kasper S (2012)
\nEuropean Group for the Study of Resistant Depression (GSRD) – where have we gone so far: review of clinical and genetic findings<\/strong>
\nEuropean Neuropsychopharmacology 22 (7): 453-468<\/p>\n

Serretti A, Chiesa A, Crisfulli C, Massat I, Linotte S, Calati R, Kasper S, Bailer U, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J (2012)
\nFailure to replicate influence of GRIK4 and GNB3 polymorphisms influence on treatment outcome in major depression<\/strong>
\nNeuropsychobiology 65 (2): 90-95<\/p>\n

Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, Savli M, Mien LK, Akimova E, Hahn A, Willeit M, Kletter K, Kasper S, Lanzenberger R (2012)
\nLight-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain<\/strong>
\nWorld Journal of Biological Psychiatry 13 (6): 413-422<\/p>\n

Stein P, Lanzenberger R, Kasper S, Aigner M (2012)
\nPsychiatrische Manifestation einer milden Form der limbischen Encephalitis<\/strong>
\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (1): 31-34<\/p>\n

Thalhammer M, Hecher S, Kasper S (2012)
\nDepression<\/strong>
\nhttp:\/\/www.netdoktor.at\/krankheiten\/fakta\/depression.htm<\/a><\/p>\n

Thalhammer M, Hecher S, Kasper S (2012)
\nMedikament\u00f6se Behandlung der Depression<\/strong>
\nhttp:\/\/www.netdoktor.at\/health_center\/depression\/medikamente.shtml<\/a><\/p>\n

Vyssoki B, Praschak-Rieder N, Sonneck G, Bl\u00fcml V, Willeit M, Kasper S, Kapusta N (2012)
\nEffects of sunshine on suicide rates<\/strong>
\nJournal of Comprehensive Psychiatry 53 (5): 535-539<\/p>\n

\u00bb zum Download<\/a>\t\t[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

[et_pb_section fb_built=“1″ _builder_version=“4.9.4″ _module_preset=“a101c382-f6f4-4378-9eee-5c6c65b689e1″ locked=“off“][et_pb_row _builder_version=“4.9.3″ _module_preset=“default“ custom_padding=“||10px||false|false“][et_pb_column type=“4_4″ _builder_version=“4.9.3″ _module_preset=“default“][et_pb_post_title _builder_version=“4.9.3″ _module_preset=“7fd05a31-4b65-4680-8d87-3be606eca9dc“][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“section“ _builder_version=“3.22″][et_pb_row admin_label=“row“ _builder_version=“4.9.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“ hover_enabled=“0″ box_shadow_style=“preset1″ custom_padding=“40px|40px|40px|40px|true|true“ custom_padding_last_edited=“on|phone“ sticky_enabled=“0″ custom_padding_phone=“|20px||20px|true|true“][et_pb_column type=“4_4″ _builder_version=“3.25″ custom_padding=“|||“ custom_padding__hover=“|||“][et_pb_text admin_label=“Text“ _builder_version=“3.27.4″ background_size=“initial“ background_position=“top_left“ background_repeat=“repeat“] Ausgew\u00e4hlte Publikationen f\u00fcr das Jahr 2012 Aktuelle Forschungsarbeiten der Klinischen Abteilung f\u00fcr Biologische Psychiatrie, Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":97,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"\n\t\t\t\t

Ausgew\u00e4hlte Publikationen f\u00fcr das Jahr 2012<\/h2>\n\nAktuelle Forschungsarbeiten der Klinischen Abteilung f\u00fcr Biologische Psychiatrie, Universit\u00e4tsklinik f\u00fcr Psychiatrie und Psychotherapie, Wien\nAbteilungsvorstand:<\/strong>\nO. Univ. Prof. Dr.h.c.mult. Dr.med. Siegfried Kasper:\nsci-biolpsy@meduniwien.ac.at<\/a>\n\n

<\/a>Publikationen 2012<\/h2>\nH\u00f6flich A, Baldinger P, Savli M, Lanzenberger R, Kasper S.\n\nImaging treatment effects in depression\nRev Neurosci. 2012;23(3):227-52<\/a>\n\nAkimova E, Kasper S (2012)\nAuf einen Blick: Burnout Syndrom und Depression: Eine oder zwei Seiten einer Medaille?<\/strong>\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (4): 190-193\n\nBaghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, M\u00f6ller HJ for the World Psychiatric Association (WPA) section of pharmacopsychiatry (2012)\nExecutive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders<\/strong>\nEuropean Archives of Psychiatry and Clinical Neuroscience 262 (1): 13-22\n\nBaldinger P, Hahn A, Friedl M, Kranz GS, Ungersb\u00f6ck J, H\u00f6flich A, Mitterhauser M, Rujescu D, Wadsak W, Lanzenberger R, Kasper S (2012)\nEinfluss der HTR1A-Polymorphismus rs878567 auf das Serotonin-1A-Bindingspotenzial in vivo<\/strong>\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (1): 36-38\n\nBandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, M\u00f6ller HJ on behalf of the WFSBP Task Force on Mental Disorders in Primary Care and the WFSBP Task Force on Anxiety Disorders, OCD and PTSD (2012)\nGuidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders in primary care<\/strong>\nInternational Journal of Psychiatry in Clinical Practice 16 (2): 77-84\n\nBauer M, Praschak-Rieder N, Kasper S, Willeit M (2012)\nIs dopamine neurotransmission altered in prodromal schizophrenia? A review of evidence<\/strong>\nCurrent Pharmaceutical Design 18 (12): 1568-1579\n\nBoubela RN, Huf W, Kalcher K, Sladky R, Filzmoser P, Pezawas L, Kasper S, Windischberger C, Moser E (2012)\nA highly parallelized framework for computationally intensive MR data analysis<\/strong>\nMagnetic Resonance Materials in Physics, Biology and Medicine 25 (4): 313-320\n\nFagiolini A, Comandini A, Dell\u2019Osso MC, Kasper S (2012)\nRediscovering trazodone for the treatment of major depressive disorder<\/strong>\nCNS Drugs 26 (12): 1033-1049\n\nFink M, Meshkat D, Kasper S, Winkler D (2012)\nPsychische und Verhaltensst\u00f6rungen bei Demenz<\/strong>\nCliniCum neuropsy 1: 22-25\n\nFischer R, Winkler D, Pjrek E, Kasper S (2012)\nOn the application of light therapy in German speaking countries<\/strong>\nEuropean Archives of Psychiatry and Clinical Neurosciences 262 (6): 501-505\n\nFountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, M\u00f6ller HJ, Vieta E (2012)\nEfficacy of pharmacotherapy in bipolar disorder: a report by the WPA section of pharmacopsychiatry<\/strong>\nEuropean Archives of Psychiatry and Clinical Neuroscience 262 (Suppl. 1): 1-48\n\nGrunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, M\u00f6ller HJ, Kasper S and the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2012)\nThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania<\/strong>\nThe World Journal of Biological Psychiatry 10: 85-116 Japanese translation from the English language edition. Tokyo: Seiwa Shoten Publishers\n\nHahn A, Nics L, Baldinger P, Ungersb\u00f6ck J, Dolliner P, Frey R, Birkfellner W, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2012)\nCombining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C] WAY-100635 independent of arterial sampling<\/strong>\nNeuroImage 62 (3): 199-206\n\nHahn A, Wadsak W, Windischberger C, Baldinger P, H\u00f6flich A, Losak J, Nics L, Philippe C, Kranz GS, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R (2012)\nDifferential modulation of the default mode network via serotonin-1A receptors<\/strong>\nPNAS 109 (7): 2619-2624\n\nH\u00f6flich A, Baldinger P, Lanzenberger S, Kasper S, Winkler D (2012)\nSteckbrief seltener Krankheiten: Das Charles Bonnet Syndrom<\/strong>\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (4): 187-189\n\nH\u00f6flich A, Baldinger P, Savli M, Lanzenberger R, Kasper S (2012)\nImaging treatment effects in depression<\/strong>\nReviews in the Neurosciences 23 (3): 227-252\n\nH\u00f6flich A, Kraus C, Frey R, Lanzenberger R, Kasper S (2012) Morphologische Ver\u00e4nderungen im ZNS. CliniCum neuropsy 1: 28-30 Kasper S (2012)\nCinical data in early intervention<\/strong>\nInternational Psychogeriatrics 24 (Suppl. 1): S41- 45\n\nKasper S (2012)\nPhytotherapie bei Stress und sogenanntem Burnout<\/strong>\nPhytotherapie Austria 4: 4-5\n\nKasper S (2012)\nPsychiatrie, raus aus der Tabuzone! Trends & Perspektiven in der Psychiatrie<\/strong>\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (1): 3\n\nKasper S (2012)\nThe challenge of treating severe depression<\/strong>\nDepression Tribune 14: 1\n\nKasper S (2012)\nVorwort. In: Gregor S: D-Day 24 Stunden der Entscheidung \u2013 mein Kampf gegen die Depression<\/strong>\nM\u00fcnchen: Scorpio Verlag, pp. 6-8\n\nKasper S, Ebert B, Larsen K, Tonnoir B (2012)\nCombining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder<\/strong>\nInternational Journal of Neuropsychopharmacology 15 (6): 715-725\n\nKasper S, Glehr R, Hasiba B, Heckenthaler W, Kapfhammer HP, Psota G, Rados C, Schultes H (2012)\nExperten Statement: Diagnose und Therapie der Generalisierten Angstst\u00f6rung (GAD) in der allgemeinmedizinischen und psychiatrischen Praxis. Schnittstellenmanagement und Stellenwert von Pregabalin. (Update Europe)<\/strong>\nInternationale Zeitschrift f\u00fcr \u00e4rztliche Fortbildung 18 (ISSN 1726-0027)\n\nKasper S, Hofmann P, Erfurth A, Frey R, H\u00f6gl B, Jenny T, Klier C, Leuteritz I, Popovic R, Pramsohler B, Rados C, Rainer M, Rie\u00dfland-Seifert A, Saletu B, Saletu-Zyhlarz G, Stelzig M, Walter E, Wuschitz A (2012)\nSchlafst\u00f6rungen bei psychiatrischen Erkrankungen<\/strong>\nKonsensus-Statement - State of the art 2012<\/strong>\nClinicum neuropsy Sonderausgabe November 2012)\n\nKasper S, Lehofer M, Doering S, Geretsegger C, Frey R, Haring C, Hausmann A, Hofmann P, Jelem H, Kalousek M, Kapfhammer HP, Klier C, Oberlerchner H, Rados C, Rothenh\u00e4usler HB, Sachs GM, Praschak-Rieder N, Psota G, Rainer M, Windhager E, Winkler D, Wrobel M (2012)\nDepression \u2013 Medikament\u00f6se Therapie. Konsensus-Statement - State of the art 2012<\/strong>\nClinicum neuropsy Sonderausgabe November 2012\n\nKasper S, Marksteiner J, Jilma B, Kutzelnigg A, Sachs G, Varadi E, Fruhw\u00fcrth G, Geretsegger C, Kastner A, Kaufmann D, Kopeinig M, Miksch G, Pfersmann V, Praschak-Rieder N, Stetter R, Toth A, Winklbaur-Hausknost B, Wrobel M (2012)\nInnovative Depottherapie bei Schizophrenie<\/strong>\nCliniCum neuropsy Sonderausgabe M\u00e4rz 2012\n\nKasper S, Rados C, Rittmannsberger H, Lenzinger E, Konstantinidis A, Hummer M, Geretsegger C (2012)\nAntidepressive Therapie mit Agomelatin in der Praxis \u2013 Ergebnisse einer Beobachtung an Patienten unter Alltagsbedingungen<\/strong>\nSonderdruck September 2012 Servier Austria\n\nKasper S, Schosser S, Lanzenberger R (2012)\nTrends und Perspektiven in der Psychiatrie: Bildgebung und Genetik in der Psychiatrie \u2013 quo vadis?<\/strong>\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (4): 168-169\n\nKindler J, Frey R, Kasper S (2012) Do antidepressants increase the risk of suicide? In: Shrivastava A, Kimbrell M, Lester D (ed.)\nSuicide from a global perspective: vulnerable populations and controversies<\/strong>\nHauppauge: Nova Science Publishers, pp. 101-110\n\nKonstantinidis A, Kasper S (2012) Stottern induziert durch Psychopharmaka. CliniCum neuropsy 5: 28-29 Konstantinidis A, Papageorgiou K, Grohmann R, Horvath A, Engel R, Kasper S (2012)\nIncrease of antipsychotic medication in depressive inpatients from 2000 to 2007: Results from the AMSP International Pharmacovigilance Program<\/strong>\nInternational Journal of Neuropsychopharmacology 15 (4): 449-457\n\nKonstantinidis A, Stamenkovic M, Kasper S (2012) Krampfanfall unter Kombinationsbehandlung. CliniCum neuropsy 1: 46-47 Kostantinidis A, Kasper S (2012)\nDepression \u2013 neue therapeutische Optionen<\/strong>\n\u00c4rzte Woche 6: 22\n\nKraft U, Hecher A, Kasper S (2012)\nDysthymie<\/strong>\nhttp:\/\/www.netdoktor.at\/krankheiten\/fakta\/dysthymie.shtml<\/a>\n\nKraus C, Hahn A, Savli M, Kranz G, Baldinger P, H\u00f6flich A, Spindelegger C, Ungersboeck J, Haeusler D, Mitterhauser M, Windischberger C, Wadsak W, Kasper S, Lanzenberger R (2012) Serotonin 1A receptor binding is positively is associated with gray matter volume - a multimodal neuroimaing study cmbining PET and structural MRI<\/strong>\nNeuroimage 63 (3): 1091-1098\n\nLanzenberger R, Kranz G, H\u00e4usler D, Akimova E, Savli M, Hahn A, Wadsak W, Spindelegger C, Philippe C, Fink M, Mitterhauser M, Kasper S (2012) <\/strong>\nPrediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas<\/strong>\nNeuroImage 63 (2): 874-881\n\nLetmaier M, Painold A, Holl AK, Vergin H, Engel R, Konstantinidis A, Kasper S, Grohmann R (2012)\nHyponatremia during psychopharmacological treatment \u2013 a result of a drug surveillance program<\/strong>\nInternational Journal of Neuropsychopharmacology 15 (6): 739-748\n\nMendlewicz J, Crisafulli C, Calati R, Kocabas NA, Massat I, Linotte S, Kasper S, Fink M, Sidoti A, Scantamburlo G, Ansseau M, Antonijevic I, Forray C, Snyder L, Bollen J, Montgomery S, Zohar J, Serretti A (2012)\nInfluence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression<\/strong>\nNeuroscience Letters 516 (1): 85-88\n\nM\u00f6ller HJ, Bitter I, Bobes J, Fountoulakis K, H\u00f6schl C, Kasper S (2012)\nPosition statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression<\/strong>\nEuropean Psychiatry 27 (2): 114-12\n\nNaderi-Heiden A, Gleiss A, Baecker C, Bieber D, Nassan-Agha H, Kasper S, Frey R (2012)\nMortality and employment after in-patient opiate detoxification<\/strong>\nEuropean Psychiatry 27 (4): 294-300\n\nPjrek E, Frey R, Naderi-Heiden A, Strnad A, Kowarik A, Kasper S, Winkler D (2012)\nActigraphic measurements in opioid detoxification with methadone or buprenorphine<\/strong>\nJournal of Clinical Psychopharmacology 32 (1): 75-82\n\nSavli M, Bauer A, Mitterhauser M, Ding YS, Hahn A, Kroll T, Neumeister A, H\u00e4usler D, Ungersb\u00f6ck J, Henry S, Attaripour Isfahani A, Rattay F, Wadsak W, Kasper S, Lanzenberger R (2012)\nNormative database of the serotonergic system in healthy subjects using multi-tracer PET<\/strong>\nNeuroImage 63 (1): 447-459\n\nSchl\u00e4pfer T, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt D, Kasper S (2012)\nThe hidden third: improving outcome in treatment resistant depression<\/strong>\nJournal of Psychopharmacology 26 (5): 587-602\n\nSchosser A, Calati R, Serretti A, Massat I, Kocabas NA, Papageorgiou K, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S (2012)\nThe impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder \u2013 A European Multicenter Study<\/strong>\nEuropean Neuropsychopharmacology 22 (4): 259-266\n\nSchosser A, Serretti A, Souery D, Mendlewicz J, Montgomery S, Kasper S (2012)\nEuropean Group for the Study of Resistant Depression (GSRD) - where have we gone so far: review of clinical and genetic findings<\/strong>\nEuropean Neuropsychopharmacology 22 (7): 453-468\n\nSerretti A, Chiesa A, Crisfulli C, Massat I, Linotte S, Calati R, Kasper S, Bailer U, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J (2012)\nFailure to replicate influence of GRIK4 and GNB3 polymorphisms influence on treatment outcome in major depression<\/strong>\nNeuropsychobiology 65 (2): 90-95\n\nSpindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, Savli M, Mien LK, Akimova E, Hahn A, Willeit M, Kletter K, Kasper S, Lanzenberger R (2012)\nLight-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain<\/strong>\nWorld Journal of Biological Psychiatry 13 (6): 413-422\n\nStein P, Lanzenberger R, Kasper S, Aigner M (2012)\nPsychiatrische Manifestation einer milden Form der limbischen Encephalitis<\/strong>\nJournal f\u00fcr Neurologie, Neurochirurgie und Psychiatrie 13 (1): 31-34\n\nThalhammer M, Hecher S, Kasper S (2012)\nDepression<\/strong>\nhttp:\/\/www.netdoktor.at\/krankheiten\/fakta\/depression.htm<\/a>\n\nThalhammer M, Hecher S, Kasper S (2012)\nMedikament\u00f6se Behandlung der Depression<\/strong>\nhttp:\/\/www.netdoktor.at\/health_center\/depression\/medikamente.shtml<\/a>\n\nVyssoki B, Praschak-Rieder N, Sonneck G, Bl\u00fcml V, Willeit M, Kasper S, Kapusta N (2012)\nEffects of sunshine on suicide rates<\/strong>\nJournal of Comprehensive Psychiatry 53 (5): 535-539\n\n\u00bb zum Download<\/a>\t\t","_et_gb_content_width":"","footnotes":""},"class_list":["post-320","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oegpb.at\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=320"}],"version-history":[{"count":2,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/320\/revisions"}],"predecessor-version":[{"id":5989,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/320\/revisions\/5989"}],"up":[{"embeddable":true,"href":"https:\/\/oegpb.at\/index.php?rest_route=\/wp\/v2\/pages\/97"}],"wp:attachment":[{"href":"https:\/\/oegpb.at\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}